Trials / Terminated
TerminatedNCT00046761
A Study to Evaluate the Effects of ONO-2506 Intravenous Infusion in Patients With Acute Ischemic Stroke
- Status
- Terminated
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 1,320 (planned)
- Sponsor
- Ono Pharma USA Inc · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to compare the efficacy of ONO-2506 versus placebo in neurological stroke outcome in patients with acute ischemic stroke.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ONO-2506 |
Timeline
- Start date
- 2002-11-01
- Primary completion
- 2005-05-01
- First posted
- 2002-10-04
- Last updated
- 2012-10-11
Locations
148 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT00046761. Inclusion in this directory is not an endorsement.